echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Rheumatology: Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation, which can be reversed by inflammatory control

    Rheumatology: Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation, which can be reversed by inflammatory control

    • Last Update: 2022-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Objective: To evaluate the effects of rheumatoid arthritis (RA) and disease-modifying antirheumatic drugs (DMARDs) on intestinal permeabilit.


    Methods: To investigate the integrity of the colonic mucosa, the claudin proteins ZO-1, occludin and claudin-2 were quantified by immunohistochemical staining in colon biopsies from 20 RA patients and 20 age- and sex-matched control.


    To explore intestinal permeability, in another cohort of 59 RA patients—21 DMARDs-naïve patients (17 before and after introduction of conventional synthetic (cs) DMARDs), 38 severe RA patients (before and after introduction of biologics) (b) before and after DMARD), and 33 healthy controls, serum concentrations of LPS-binding protein (LBP), sCD14, and zonulin-related protein (ZRP) were assessed by ELIS.


    Results: The expression of ZO-1 protein in colon of RA patients was lower than that of controls (mean score ± SE: 6 ± 56 vs 0 ± 43, p=01), while no significant difference was detected in occludin and claudin-2.

    Serum LBP and sCD14 concentrations were higher in RA patients than in control.


    Unlike bDMARD non-responders and patients treated with csDMARDs, bDMARD responders had significantly lower LBP and sCD14 concentration.


    Conclusions: Colonic tight junction proteins are altered in RA patients and serum biomarkers of intestinal permeability are increase.


    Source:

    Audo R, Sanchez P, Rivière B, et a.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.